332 related articles for article (PubMed ID: 14623801)
1. Preprocedural level of soluble CD40L is predictive of enhanced inflammatory response and restenosis after coronary angioplasty.
Cipollone F; Ferri C; Desideri G; Paloscia L; Materazzo G; Mascellanti M; Fazia M; Iezzi A; Cuccurullo C; Pini B; Bucci M; Santucci A; Cuccurullo F; Mezzetti A
Circulation; 2003 Dec; 108(22):2776-82. PubMed ID: 14623801
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of preprocedural soluble CD40 ligand for predicting restenosis after percutaneous coronary intervention in patients with stable coronary artery disease.
Türker S; Güneri S; Akdeniz B; Ozcan MA; Baris N; Badak O; Kirimli O; Yüksel F
Am J Cardiol; 2006 Jan; 97(2):198-202. PubMed ID: 16442363
[TBL] [Abstract][Full Text] [Related]
3. Enhanced soluble CD40 ligand contributes to endothelial cell dysfunction in vitro and monocyte activation in patients with diabetes mellitus: effect of improved metabolic control.
Cipollone F; Chiarelli F; Davì G; Ferri C; Desideri G; Fazia M; Iezzi A; Santilli F; Pini B; Cuccurullo C; Tumini S; Del Ponte A; Santucci A; Cuccurullo F; Mezzetti A
Diabetologia; 2005 Jun; 48(6):1216-24. PubMed ID: 15868137
[TBL] [Abstract][Full Text] [Related]
4. The presence of metabolic syndrome is independently associated with elevated serum CD40 ligand and disease severity in patients with symptomatic coronary artery disease.
Lee WL; Lee WJ; Chen YT; Liu TJ; Liang KW; Ting CT; Huey-Herng Sheu W
Metabolism; 2006 Aug; 55(8):1029-34. PubMed ID: 16839837
[TBL] [Abstract][Full Text] [Related]
5. Platelets and cytokines in concert with endothelial activation in patients with peripheral arterial occlusive disease.
Tsakiris DA; Tschöpl M; Wolf F; Labs KH; Jäger KA; Marbet GA
Blood Coagul Fibrinolysis; 2000 Mar; 11(2):165-73. PubMed ID: 10759010
[TBL] [Abstract][Full Text] [Related]
6. Soluble CD40 ligand in pulmonary arterial hypertension: possible pathogenic role of the interaction between platelets and endothelial cells.
Damås JK; Otterdal K; Yndestad A; Aass H; Solum NO; Frøland SS; Simonsen S; Aukrust P; Andreassen AK
Circulation; 2004 Aug; 110(8):999-1005. PubMed ID: 15302794
[TBL] [Abstract][Full Text] [Related]
7. Relationship between upregulation of CD40 system and restenosis in patients after percutaneous coronary intervention.
Yan JC; Ding S; Liang Y; Ma GS; Zhu J; Feng Y; Luo D
Acta Pharmacol Sin; 2007 Mar; 28(3):339-43. PubMed ID: 17302995
[TBL] [Abstract][Full Text] [Related]
8. Expression of polymorphonuclear leukocyte adhesion molecules and its clinical significance in patients treated with percutaneous transluminal coronary angioplasty.
Inoue T; Sakai Y; Morooka S; Hayashi T; Takayanagi K; Takabatake Y
J Am Coll Cardiol; 1996 Nov; 28(5):1127-33. PubMed ID: 8890805
[TBL] [Abstract][Full Text] [Related]
9. Platelet-derived chemokine RANTES may be a sign of restenosis after percutaneous coronary intervention in patients with stable angina pectoris.
Inami N; Nomura S; Manabe K; Kimura Y; Iwasaka T
Platelets; 2006 Dec; 17(8):565-70. PubMed ID: 17127484
[TBL] [Abstract][Full Text] [Related]
10. Variations in inflammatory markers in acute myocardial infarction: a longitudinal study.
Napoleão P; Santos MC; Selas M; Viegas-Crespo AM; Pinheiro T; Ferreira RC
Rev Port Cardiol; 2007 Dec; 26(12):1357-63. PubMed ID: 18338665
[TBL] [Abstract][Full Text] [Related]
11. Periprocedural soluble P- and E-selectin levels fail as predictors of clinical restenosis in patients treated with elective coronary stenting.
Kozinski M; Kubica J; Sukiennik A; Zbikowska-Gotz M; Krzewina-Kowalska A; Radomski M; Rychter M; Bialoszynski T; Jablonski M; Demidowicz K; Grzesk G; Bogdan M; Chojnicki M; Grabczewska S; Dziedziczko A
Int J Mol Med; 2007 Jan; 19(1):187-95. PubMed ID: 17143564
[TBL] [Abstract][Full Text] [Related]
12. Serum prostaglandin D synthase level after coronary angioplasty may predict occurrence of restenosis.
Inoue T; Takayanagi K; Morooka S; Uehara Y; Oda H; Seiki K; Nakajima H; Urade Y
Thromb Haemost; 2001 Jan; 85(1):165-70. PubMed ID: 11204569
[TBL] [Abstract][Full Text] [Related]
13. Sustained elevation of serum CD40 ligand levels one month after coronary angioplasty predicts angiographic restenosis.
L'Allier PL; Tardif JC; Grégoire J; Joyal M; Lespérance J; Fortier A; Guertin MC
Can J Cardiol; 2005 May; 21(6):495-500. PubMed ID: 15917878
[TBL] [Abstract][Full Text] [Related]
14. Increased plasma soluble adhesion molecules; ICAM-1, VCAM-1, and E-selectin levels in patients with slow coronary flow.
Turhan H; Saydam GS; Erbay AR; Ayaz S; Yasar AS; Aksoy Y; Basar N; Yetkin E
Int J Cardiol; 2006 Apr; 108(2):224-30. PubMed ID: 16002164
[TBL] [Abstract][Full Text] [Related]
15. Plasma soluble adhesion molecules and endothelium-dependent vasodilation in early human atherosclerosis.
John S; Jacobi J; Delles C; Schlaich MP; Alter O; Schmieder RE
Clin Sci (Lond); 2000 May; 98(5):521-9. PubMed ID: 10781382
[TBL] [Abstract][Full Text] [Related]
16. Short-term treatment with atorvastatin reduces platelet CD40 ligand and thrombin generation in hypercholesterolemic patients.
Sanguigni V; Pignatelli P; Lenti L; Ferro D; Bellia A; Carnevale R; Tesauro M; Sorge R; Lauro R; Violi F
Circulation; 2005 Feb; 111(4):412-9. PubMed ID: 15687128
[TBL] [Abstract][Full Text] [Related]
17. [Expression of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in the pig coronary artery injury model: comparison of plain old balloon angioplasty and stent implantation].
Shimizu N; Suzuki H; Wakabayashi K; Iso Y; Shibata M; Yorozuya M; Katagiri T; Takeyama Y
J Cardiol; 2004 Mar; 43(3):131-9. PubMed ID: 15067801
[TBL] [Abstract][Full Text] [Related]
18. Soluble CD40L in patients with morbid obesity: significant reduction after bariatric surgery.
Schernthaner GH; Kopp HP; Krzyzanowska K; Kriwanek S; Koppensteiner R; Schernthaner G
Eur J Clin Invest; 2006 Jun; 36(6):395-401. PubMed ID: 16684123
[TBL] [Abstract][Full Text] [Related]
19. Elevated circulating levels of soluble CD-40 ligand in haemodialysis patients with symptomatic coronary heart disease.
Lim PS; Wu MY; Chien SW; Wu TK; Liu CS; Hu CY; Chang HC; Pai MA
Nephrology (Carlton); 2008 Dec; 13(8):677-83. PubMed ID: 19019166
[TBL] [Abstract][Full Text] [Related]
20. Protection from procedural myocardial injury by atorvastatin is associated with lower levels of adhesion molecules after percutaneous coronary intervention: results from the ARMYDA-CAMs (Atorvastatin for Reduction of MYocardial Damage during Angioplasty-Cell Adhesion Molecules) substudy.
Patti G; Chello M; Pasceri V; Colonna D; Nusca A; Miglionico M; D'Ambrosio A; Covino E; Di Sciascio G
J Am Coll Cardiol; 2006 Oct; 48(8):1560-6. PubMed ID: 17045888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
